logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Biostatistical considerations in pharmacovigilance and pharmacoepidemiology : Linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studies.

    Article, Communication - En anglais

    International conference on "Statistical issues in pharmaceutical development ; collaboration between Europe and the USA ; regulation of medicines from research to marketing". Leicester, GBR, 1996/07/16.

    This paper deals with a conceptual discussion of a variety of statistical concepts, methods and strategies that are relevant to the quantitative assessment of risk derived from safety data collected during the pre-and post-marketing phase of a new drug's life cycle.

    A call is made for the use of more standard approaches to the analysis of safety data that are statistically and epidemiologically rigorous and for attempts to link the strategies for pre-market safety assessment with strategies for post-market safety evaluation.

    This link may be facilitated by recognizing the limitations and complementary roles played by pre-and post-market safety data collection schemes and by linking the quantitative analyses utilized for either exploratory or confirmatory purposes of risk assessment in each phase of safety data collection.

    Examples are provided of studies specifically designed to evaluate risk in a post approval setting and several available guidelines intended to improve the quality of these studies are discussed.

    Mots-clés Pascal : Analyse risque, Pharmacovigilance, Epidémiologie, Analyse statistique, Analyse quantitative, Autorisation mise sur marché, Commercialisation, Analyse donnée

    Mots-clés Pascal anglais : Risk analysis, Pharmacovigilance, Epidemiology, Statistical analysis, Quantitative analysis, Marketing authorization, Marketing, Data analysis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0446001

    Code Inist : 002B02A06. Création : 25/01/1999.